News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GenMark Diagnostics (GNMK) Submits Respiratory Viral Panel Test for FDA 510(k) Clearance



12/22/2011 6:14:59 AM

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc., (NASDAQ: GNMK) announced today that it has submitted to the U.S. Food and Drug Administration (FDA), for 510(k) clearance, a Respiratory Viral Panel for use on its eSensor® XT-8 system. The test is designed to identify multiple viruses from individuals exhibiting signs and symptoms of respiratory infection. The eSensor Respiratory Viral Panel is designed to be a fast, easy-to-use molecular diagnostic test to provide accurate results while requiring less technologist time.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES